NHS
Cancer Drugs Fund to offer MSD’s Keytruda for lung cancer
November 22, 2018Sales and Marketing CDF, Cancer, Cancer Drugs Fund, NHS, NICE, UK, keytruda, pharma
MSD’s Keytruda (pembrolizumab) will now be made available via the Cancer Drugs Fund for patients in England, as NICE announces …
MSD’s Keytruda to treat melanoma in England on the Cancer Drugs Fund
November 19, 2018Sales and Marketing England, MSD, NHS, UK, keytruda, melanoma, pharma
MSD’s blockbuster immunotherapy Keytruda (pembrolizumab) will now be made available to patients in England via the Cancer Drugs Fund, it …
Kymriah to be made available in UK for paediatric leukaemia patients via Cancer Drugs Fund
November 15, 2018Sales and Marketing CAR-T, Cancer, Cancer Drugs Fund, Kymriah, NHS, NICE, leukaemia, pharma
NICE has announced its recommendation that Novartis’ CAR-T cell therapy Kymriah (tisagenlecleucel) be made available in the treatment of relapsed …
Eisai’s Lenvima wins over NICE in liver cancer in just three months
November 9, 2018Medical Communications, Sales and Marketing Cancer, Eisai, Lenvima, Levantinib, NHS, NICE, UK, liver cancer, pharma
Eisai has revealed that its multireceptor Tyrosine Kinase Inhibitor Lenvima (lenvatinib) has been recommended by NICE, meaning it can now …
NICE fail to recommend AstraZeneca’s cancer drug Olaparib on cost effectiveness basis
November 9, 2018Medical Communications, Sales and Marketing AstraZeneca, NHS, NICE, UK, olaparib, pharma
Britain’s cost effectiveness body the National Institute of Health and Care Excellence (NICE) has chosen not to recommend AstraZeneca’s Olaparib …
NHS diabetes prescriptions top £1 billion a year
November 9, 2018Medical Communications, Sales and Marketing Health Education England, NHS, UK, diabetes, pharma
The NHS in England is now spending over £1billion a year on diabetes prescriptions, almost doubling in the last decade, …
Jazz Pharma’s Vyxeos secures NICE recommendation in acute myeloid leukaemia
November 8, 2018Sales and Marketing Cancer, NHS, NICE, UK, Vyxeos, acute myeloid leukaemia, jazz pharmaceuticals, pharma
Jazz Pharmaceuticals has revealed that NICE has chosen to recommend that its 44mg/100mg powder formulation of Vyxeos for concentrate for …
AbbVie sue NHS over hepatitis C drug procurement
November 8, 2018Business Services AbbVie, NHS, britain, court, hep C, hepatitis, ruling
American pharma firm AbbVie are suing Britain’s NHS after claiming that the health service’s procurement of hepatitis C drugs breached …
Health Secretary launches new prevention strategy for NHS
November 6, 2018Manufacturing and Production Matt Hancock, NHS, health, prevention
British Health Secretary Matt Hancock has said that healthcare should focus on prevention, as he launched a long-term strategy intended …
Metropolitan Police charge ITH Pharma over IV feed-linked baby deaths
October 31, 2018Research and Development ITH Pharma, Metropolitan Police, NHS, pharma
An investigation into the deaths and illnesses of several babies at a number of UK hospitals has prompted London’s Metropolitan …
NICE turns down Sanofi’s Caprelsa for rare thyroid cancer
October 31, 2018Research and Development, Sales and Marketing Cancer, Caprelsa, NHS, NICE, Sanofi, UK, medullary thyroid cancer, pharma
NICE has announced its recommendation to reject Sanofi’s Caprelsa (vandetanib) for use on the NHS in the treatment of medullary …
Half of kidney cancer patients initially misdiagnosed
October 30, 2018Manufacturing and Production Cancer, Kidney cancer, NHS, UK, diagnosis
Half of kidney cancer patients are initially misdiagnosed, according to data from Kidney Cancer UK’s patient survey. Despite being the …
NHS to receive additional £20.5 billion each year from 2018 Budget
October 30, 2018Manufacturing and Production Budget, Conservatives, Labour, NHS, mental health, politics
The NHS will receive an additional £20.5 billion a year until 2023-24, according to the Budget released yesterday. The confirmation …
NICE issues draft guidance rejecting Abbvie’s Venclyxto in chronic lymphocytic leukaemia
October 26, 2018Medical Communications, Sales and Marketing AbbVie, NHS, NICE, leukaemia, pharma, venetoclax
It’s bad news for patients in the UK affected by chronic lymphocytic leukaemia (CLL) as the National Institute of Health …
Novartis and Bayer seek to oppose High Court ruling over NHS decision to use cheaper drug
October 16, 2018Manufacturing and Production Bayer, CCG, NHS, Novartis, avastin, wet AMD
Swiss multinational Novartis have joined German pharma firm Bayer in appealing a High Court ruling over 12 NHS clinical commissioning …
Latest content
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?
